Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-19175
Publication type: Working paper – expertise – study
Title: Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description
Authors: Eichler, Klaus
Rapold, Ronald
Wieser, Simon
Reich, Oliver
Blozik, Eva
et. al: No
DOI: 10.21256/zhaw-19175
Extent: 1-37
Issue Date: Oct-2019
Publisher / Ed. Institution: ZHAW Zürcher Hochschule für Angewandte Wissenschaften
Publisher / Ed. Institution: Winterthur
Language: English
Subjects: Multiple myeloma; Drug treatment; Treatment patterns; Costs
Subject (DDC): 362.1041: Health economics
615: Pharmacology and therapeutics
URI: https://digitalcollection.zhaw.ch/handle/11475/19175
License (according to publishing contract): CC BY 4.0: Attribution 4.0 International
Departement: School of Management and Law
Organisational Unit: Winterthur Institute of Health Economics (WIG)
Appears in collections:Gesundheitsökonomie

Files in This Item:
File Description SizeFormat 
Multiple Myeloma Drug Regimes_2019.pdf527.94 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.